Skip to main content
Caplight Logo









Computomics

Computomics

Private
TübingenHealthcare & Life Scienceshttps://www.computomics.com/home.html

Last Round

Series B

Aug 18, 2026

Total Funding Raised

$10.47M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Computomics is a biotechnology company that provides bioinformatics data analysis services and predictive machine learning technology for the agricultural and biotechnology sectors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, ML Platforms, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

bioinformaticspredictive breedingagtechgenomic analysisplant breedingmetagenomicspangenome analysisdigital breedingmachine learningbioinformatics consultingphenotypic datacrop resiliencedata harmonizationbiotech softwarecomputational biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Computomics Comparables

Compare Computomics with similar companies based on industry and business-model similarity.

Computomics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NRGene Technologies
84%
Calice Biotech
83%
Nature Source Improved Plants
81%

Computomics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BAug 18, 2026
GrantJun 23, 2022
Series AOct 14, 2021
AcceleratorJul 3, 2020
SeedOct 27, 2015

Computomics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 18, 2026

    $7.3M round led by conventcapital

  • Oct 14, 2021

    Led by BASF Venture Capital and Amathaon Capital.

Recent news

Latest coverage and updates

  • receives_financingAug 19, 2026

    Computomics received financing of $7.29M in Series B on Aug 19th '26.

  • launchesJun 22, 2026

    Computomics GmbH launched "Make Sense of Science" explainer series on Jun 18th '26.

Computomics Filings

Explore SEC and related filing metadata, where available.

Computomics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Computomics's valuation, stock price, and market status.

Is Computomics a public or private company?

Computomics is a private company.

What is the current stock price of Computomics?

Computomics is a private company with no public stock price. No recent secondary market data is available.

How much is Computomics worth (valuation)?

Valuation information for Computomics is not publicly available.

Can I buy Computomics stock?

Computomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Computomics's last funding round?

Computomics's most recent funding round was Grant on June 28, 2022.

Who are the main investors in Computomics?

Key investors in Computomics include Amathaon Capital, BASF Venture Capital.

Will Computomics IPO soon?

No public IPO plans have been announced for Computomics.

How can I track Computomics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Computomics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTübingen
Employee Range32
Year Founded2012
Last FundingAug 18, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?